The original weight is 4.
Explanation:
20%= 1/5 if u don’t know the percentage then u can simply by doing..
20/100 then u divide it. U can do this by any other numbers such as 2, 4,5,10 and 20. U can do which ever way u like but i would recommend doing it either by 10 or 20.
So if we divide it by 20 we do...
20/100 divided by 20= 1/5
Or
20/100 divided by 10= 2/10
2/10 divided by 2 = 1/5
You can see the bigger the number that fits in is faster, although u can do it any way u feel like doing.
So we have got 1/5 from 20%. Now we do...
1/5 divided by 20. So when we do this, we use the bottom number to divide it and the top number to times it.
So..
1/5 u could use as 20 divided by 5..
Then 1 times the number that u get from ur before sum.
The answer is 4.
Because 1/5= 20 divided by 5 = 4
Since we have a 1 left we do..
4 times 1 which is... 4.
( u don’t need to show these parts in doing ur working, but i am doing these so they can help u understand)
So the answer is 4 and is the original weight.
I hope this is clear and helps u! :D
Answer:
Macromolecules are transported from one space to another through a process of transcytosis or transcellular transport. It consists of a series of steps that will allow the mobility of macromolecules from one extracellular space to another, through the cellular menbrain, through a vesicle formation process. These vesicles maintain a certain load inside. The processes that are generated for the transcytosis process are those of endocytosis and exocytosis.
Answer:
Atropine is highly potent antagonist of G-Class proteins of receptors termed as muscarinic acetylcholine receptors. Atropine blocks the action of these receptors and suppress the effects caused by parasympathetic nervous system. These complications of Atropine may lead to Tachycardia in patients administrated with atropine.
Valves are like flaps or lids that are used to transport blood from the atria to the ventricles. They act as inlets and outlets of blood.
Explanation:
The atrioventricular valves are located Left and right that are in the middle of atria and ventricle on both sides of the heart while two semilunar valves separate the right and left ventricles from the pulmonary valve and aortic valve.
The Atrioventricular valves are the mitral valve and the tricuspid valve. Mitral valve is in the left side and tricuspid valve is in the right. they both are separated by the atrium and ventricle
The two semilunar valves are the pulmonary valve and aortic valve. the pulmonary valve is on the right side separated by the right ventricle and pulmonary artery. The aortic valve is on the left and is separated by the left ventricle and aorta.
A Drug Trend report published in 2009 had predicted continued price increase among traditional branded and biotech drugs that lack generic competition. Now, further, CMS has reduced its Average Sales price (ASP) margin from 6 percent to 4 percent for non-pass-thorough. This has affected pharmacy reimbursement. However, there are certain other aspects of Pharmacy Billing that can affect reimbursement and thereby the Revenue Cycle Management (RCM) process if not well implemented.
1. Data Workflow:
Recognizing how the revenue cycle works in pharmacy is very essential. Procurement to Inventory, billing and reimbursement involves purchase of medications, their storage, and method of dispensing, how they are administered, way they are coded & billed, and finally reimbursed. If the drug is covered as a pharmacy benefit, or the payer needs that to be obtained via a specialty pharmacy as identified through patient-specific benefit verification, then here both the provider and the pharmacy are part of the reimbursement process. The physician writes a prescription and orders the drug. This is followed by the pharmacy that fills the order and issues the drug to the physician, CMHC, or hospital outpatient department. Here the pharmacy bills the insurance company for the drug. If any information is entered incorrectly into the pharmacy system in the initial phase of the cycle, errors can prove to be costly, impacting aspects of clinical and revenue cycle.
2. Procurement:
During this phase information is converted from purchased quantities and pricing to storage units of measure (UOM) and inventory costs. Manually entering the data is followed in most cases. UOM conversions, when data is uploaded from the wholesale distributor to the pharmacy system, are also checked and verified manually. Here too mistakes can lead to breakdown in the revenue cycle management (RCM) process.
3. The Charge master:
Critical & substantial revenue leakage can occur when separately reimbursable medications are either missing from or miscoded in the charge master. Conversion of pharmaceutical quantities is a must from purchased amounts to patient-administered amounts, and only then made billable. There is often a difference between dosage amounts required for patient use as from that purchased. Besides inventory, the clinician and pharmacist should convert dosage, strength, and delivery mechanism for each drug. Drug data must be correctly converted from the quantities residing in clinical systems into the payer-billable quantities appropriate for the financial system or charge master. The UOMs must be reconciled to avoid any under- or over-payments. More than often, missing or incorrect data in the charge master can result in negative financial consequences – denied claims, partial reimbursement, and compliance risks.
4. Linkages between Purchases & Billing:
Most hospitals have separate processes to order drugs, administer them, and process reimbursement. Without linkage between pharmacy expenditures for medications (i.e., spend data) and the charge master, ensuring proper charge capture and optimal reimbursement is a challenge. Besides hospitals should have automated tools to identify charge capture errors precisely, so as to pinpoint when and where their occurrence to decreasing revenue loss.
